(19)
(11) EP 2 285 357 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
23.07.2014 Bulletin 2014/30

(45) Mention of the grant of the patent:
07.05.2014 Bulletin 2014/19

(21) Application number: 09753941.5

(22) Date of filing: 28.05.2009
(51) International Patent Classification (IPC): 
A61K 9/20(2006.01)
 A61K 31/00(2006.01)
(86) International application number:
PCT/EP2009/056570
(87) International publication number:
WO 2009/144286 (03.12.2009 Gazette 2009/49)

(54)

Pharmaceutical compositions comprising brivaracetam

Pharmazeutische Zusammensetzungen mit Brivaracetam

Compositions pharmaceutiques comprenant du brivaracetam

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA RS

(30) Priority: 30.05.2008 EP 08009919

(43) Date of publication of application:
23.02.2011 Bulletin 2011/08

(73) Proprietor: UCB Pharma, S.A.
1070 Brussels (BE)

(72) Inventors:
  • EECKMAN, Frédéric
    B-1070 Brussels (BE)
  • BERWAER, Monique
    B-1070 Brussels (BE)
  • FANARA, Domenico
    B-1070 Brussels (BE)

(74) Representative: UCB Intellectual Property 
c/o UCB Biopharma SPRL Intellectual Property Department Allée de la Recherche 60
1070 Brussels
1070 Brussels (BE)


(56) References cited: : 
EP-A- 1 806 339
WO-A-2007/141002
US-A1- 2006 165 796
 WO-A-2006/090275
US-A- 6 106 864
   
  • VON ROSENSTIEL ET AL: "Brivaracetam (UCB 34714)" 20061230, vol. 4, no. 1, 30 December 2006 (2006-12-30), pages 84-87, XP005735280
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).